TP53 and osteosarcoma: This finding also demonstrates that the requirement of ICMT for the correct trafficking of GFP-NRAS to the PM seems independent of the cell of origin, as similar results were observed in melanoma cells and U2OS, an osteosarcoma cell line, driven by mutations in NF1 and TP53.